Get ready for Cara Therapeutics’s earnings report set to be released on March 4, 2024. Here are some key points to keep in mind before the big announcement:
– Analysts are estimating an earnings per share (EPS) of $-0.41 for Cara Therapeutics.
– Investors will not only be looking for an earnings beat but also positive guidance for the next quarter, as this can have a significant impact on stock prices.
– In the last quarter, the company missed EPS by $0.00, resulting in a 7.2% drop in share price the following day.
– Shares of Cara Therapeutics were trading at $0.8502 as of February 29, showing a 91.22% decrease over the past year.
Stay informed by checking out Cara Therapeutics’s earnings calendar on financial websites like Benzinga and MarketBeat. This data will give you a better idea of what to expect from the upcoming earnings report and how past performance has affected stock prices.
CARA Stock Price Drops 1.20% on March 1, 2024, Trading Near 52-Week Low
On March 1, 2024, CARA stock experienced a slight decrease in price, trading near the bottom of its 52-week range and below its 200-day simple moving average. The stock opened at $0.84, $0.01 lower than its previous close, representing a 1.20% drop in price.
CARA Stock Performance Analysis: Positive Revenue Growth but Mixed Profitability Results
CARA stock had a mixed performance on March 1, 2024, as investors digested the latest financial results released by the company. According to data from CNN Money, CARA reported total revenue of $41.87 million for the past year, which represented an impressive 81.81% increase compared to the previous year. However, the total revenue for the third quarter of the year was $4.87 million, a 29.81% decrease from the previous quarter.
On the profitability front, CARA reported a net income of -$85.47 million for the past year, which was an improvement of 3.35% compared to the previous year. The net income for the third quarter of the year was -$28.03 million, representing a 10.95% increase from the previous quarter.
Earnings per share (EPS) for CARA also showed improvement, with a reported EPS of -$1.59 for the past year, an increase of 8.64% compared to the previous year. The EPS for the third quarter of the year was -$0.52, showing a further improvement of 11.32% from the previous quarter.
Overall, the financial results for CARA on March 1, 2024, showed a mix of positive and negative trends. While total revenue and net income saw improvements compared to the previous year, there was a decline in revenue and an increase in net income compared to the previous quarter. However, the increase in EPS for both the past year and the third quarter of the year was a positive sign for investors.
Investors will be closely monitoring future financial reports and company developments to gauge the overall performance and potential growth prospects of CARA stock in the coming months.
